Fenebrutinib is an Orally Active Btk Inhibitor for Cancer and Autoimmune Diseases Research
BTK is a member of the Tec family of cytoplasmic tyrosine kinases involved in B cell and myeloid cell signaling. BTK is located downstream of B cells and Fcγ receptors.…